CN1833715A - Skin care gel for skin titillation and prepn. thereof - Google Patents
Skin care gel for skin titillation and prepn. thereof Download PDFInfo
- Publication number
- CN1833715A CN1833715A CN 200610000789 CN200610000789A CN1833715A CN 1833715 A CN1833715 A CN 1833715A CN 200610000789 CN200610000789 CN 200610000789 CN 200610000789 A CN200610000789 A CN 200610000789A CN 1833715 A CN1833715 A CN 1833715A
- Authority
- CN
- China
- Prior art keywords
- skin
- gel
- make
- ethanol
- herba polygoni
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 37
- 208000003251 Pruritus Diseases 0.000 claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 109
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 81
- 239000007788 liquid Substances 0.000 claims description 51
- 238000003756 stirring Methods 0.000 claims description 36
- 238000001914 filtration Methods 0.000 claims description 34
- 238000002156 mixing Methods 0.000 claims description 34
- 238000005325 percolation Methods 0.000 claims description 34
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 27
- 229920002125 Sokalan® Polymers 0.000 claims description 27
- 229960001631 carbomer Drugs 0.000 claims description 27
- 239000002904 solvent Substances 0.000 claims description 27
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 17
- 239000000080 wetting agent Substances 0.000 claims description 12
- 230000002421 anti-septic effect Effects 0.000 claims description 11
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 10
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 10
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 10
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 9
- 239000004302 potassium sorbate Substances 0.000 claims description 9
- 235000010241 potassium sorbate Nutrition 0.000 claims description 9
- 229940069338 potassium sorbate Drugs 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 7
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 7
- 229940033663 thimerosal Drugs 0.000 claims description 7
- 229920002907 Guar gum Polymers 0.000 claims description 6
- 239000000665 guar gum Substances 0.000 claims description 6
- 235000010417 guar gum Nutrition 0.000 claims description 6
- 229960002154 guar gum Drugs 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 5
- 235000010199 sorbic acid Nutrition 0.000 claims description 5
- 229940075582 sorbic acid Drugs 0.000 claims description 5
- 239000004334 sorbic acid Substances 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 4
- 235000010489 acacia gum Nutrition 0.000 claims description 4
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- -1 tragcanth Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 18
- 201000004624 Dermatitis Diseases 0.000 abstract description 5
- 208000010668 atopic eczema Diseases 0.000 abstract description 5
- 201000009053 Neurodermatitis Diseases 0.000 abstract description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- 241001671204 Stemona Species 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 15
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 238000001556 precipitation Methods 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 239000002671 adjuvant Substances 0.000 description 8
- 208000020442 loss of weight Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 235000019445 benzyl alcohol Nutrition 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 208000035357 Focal Infection Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 206010024438 Lichenification Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Abstract
Description
Supplementary product kind | Consumption (%) | The result |
HPMC carbomer CMC-Na xanthans guar gum Arabic gum sodium alginate tragcanth polyacrylamide cross linked sodium polyacrylate polyethylene glycol | 0.9 0.4 1.0 1.0 1.0 5 5 5 2 2 4 | Make even gel, do not have precipitation and separate out.Make even gel, clarity is better, does not have precipitation and separates out.Make even gel, do not have precipitation and separate out.Make even gel, do not have precipitation and separate out.Make even gel, do not have precipitation and separate out.Make even gel, do not have precipitation and separate out.Make even gel, do not have precipitation and separate out.Make even gel, do not have precipitation and separate out.Make even gel, do not have precipitation and separate out.Make even gel, do not have precipitation and separate out.Make even gel, do not have precipitation and separate out. |
Consumption (%) | The result |
0.2 0.3 0.5 0.7 0.8 1.4 2.0 | It is rarer to make gel, and scribble effect is better.Make the gel stickiness and be fit to, easily smear.Make the gel stickiness and be fit to, easily smear.Make the gel stickiness and be fit to, easily smear.It is more sticky to make the gel stickiness, more easily smears.It is more sticky to make gel, more easily smears.It is more sticky to make gel, and scribble effect is better. |
Glycerol consumption (%) | 25 ℃ | 37 ℃ |
2357 12 | Loss of weight 2.8%.Loss of weight 1.5 losss of weight 1.1%.Loss of weight 1.0 losss of weight 0.5%. | Loss of weight 3.5%.Loss of weight 1.2 losss of weight 1.0%.Loss of weight 0.8 loss of weight 0.9%. |
Sample | Appearance character |
After testing before the test | Orange-yellow clear gel, the moderate orange-yellow clear gel of viscosity, viscosity is moderate |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100007896A CN100569217C (en) | 2006-01-11 | 2006-01-11 | A kind of preparation method that is used for the skin-care gel of skin pruritus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100007896A CN100569217C (en) | 2006-01-11 | 2006-01-11 | A kind of preparation method that is used for the skin-care gel of skin pruritus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1833715A true CN1833715A (en) | 2006-09-20 |
CN100569217C CN100569217C (en) | 2009-12-16 |
Family
ID=37001705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100007896A Expired - Fee Related CN100569217C (en) | 2006-01-11 | 2006-01-11 | A kind of preparation method that is used for the skin-care gel of skin pruritus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100569217C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101332244B (en) * | 2008-06-06 | 2011-12-21 | 叶志军 | Oral traditional Chinese medicine for treating diffused neurodermatitis |
CN103223110A (en) * | 2013-04-30 | 2013-07-31 | 布焕景 | External traditional Chinese medicine composition for treating female pruritus vulvae and preparation method thereof |
CN106138190A (en) * | 2016-08-08 | 2016-11-23 | 林湧博 | A kind of external-use gel preparation, preparation method and its usage |
CN106620445A (en) * | 2016-11-09 | 2017-05-10 | 安徽安科余良卿药业有限公司 | Skin-rehabilitating microemulsion gel and preparation method thereof |
-
2006
- 2006-01-11 CN CNB2006100007896A patent/CN100569217C/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101332244B (en) * | 2008-06-06 | 2011-12-21 | 叶志军 | Oral traditional Chinese medicine for treating diffused neurodermatitis |
CN103223110A (en) * | 2013-04-30 | 2013-07-31 | 布焕景 | External traditional Chinese medicine composition for treating female pruritus vulvae and preparation method thereof |
CN103223110B (en) * | 2013-04-30 | 2014-08-06 | 赵彦梅 | External traditional Chinese medicine composition for treating female pruritus vulvae and preparation method thereof |
CN106138190A (en) * | 2016-08-08 | 2016-11-23 | 林湧博 | A kind of external-use gel preparation, preparation method and its usage |
CN106138190B (en) * | 2016-08-08 | 2020-03-31 | 浙江奕箔生物科技有限公司 | External gel preparation, preparation method and application thereof |
CN106620445A (en) * | 2016-11-09 | 2017-05-10 | 安徽安科余良卿药业有限公司 | Skin-rehabilitating microemulsion gel and preparation method thereof |
CN106620445B (en) * | 2016-11-09 | 2020-01-03 | 安徽安科余良卿药业有限公司 | Skin-care microemulsion gel and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN100569217C (en) | 2009-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1833649A (en) | Jixuedai gel with action of promoting wound reunion, and prepn. thereof | |
CN101062289A (en) | External application medicine combination for treating gout | |
CN106138190B (en) | External gel preparation, preparation method and application thereof | |
CN101444555A (en) | Purely Chinese traditional medical film for curing oral ulcer and method for preparing same | |
CN100569217C (en) | A kind of preparation method that is used for the skin-care gel of skin pruritus | |
CN1840051B (en) | Pain-stopping gel with musk and its preparation method | |
CN1647803A (en) | Chinese medicine composition plaster for external anti-inflammation and analgetics | |
CN101278948B (en) | Biological medical membrane and method of preparing the same | |
CN1876163A (en) | Navel-adhibitting medicine for vomit-stopping in chemotherapy | |
CN1833693A (en) | Red medicine gel for treating traumatic injury and its prepn. method | |
CN1233378C (en) | Chinese medicine composition for treating oral cavity and throat diseases and its preparing method | |
CN1840129A (en) | Gel for treating gynecological disease and preparation method thereof | |
CN101028484A (en) | Chinese medicinal paste for treating tumor and its production | |
CN102793830A (en) | Pronephrium triphyllum-rheum officinale gel and preparation method thereof | |
CN1883620A (en) | Gel agent for treating superficial mycotic infection and method for preparing same | |
CN1695642A (en) | Compound gel of goldenlarch bark preparation method | |
CN1833674A (en) | Wart gel and prepn. method | |
CN102688330B (en) | Biological Chinese medicine film and preparation method thereof | |
CN1833673A (en) | Externally rubbing 'Bailing' gel for treating leucoderma and its prepn. method | |
CN101032553A (en) | Chinese traditional medicine for curing stomatocace and its producing method | |
CN101337026A (en) | External medicine composition for treating gout | |
CN1634118A (en) | Antivirus formulation containing polysaccharide polyanion zinc salt and its preparing process | |
CN104434992A (en) | Biological adhesive vaginal tablet of periplaneta americana extract and preparation method of biological adhesive vaginal tablet | |
CN1631425A (en) | Lozenge for treating its pharyngitis and preparation process thereof | |
CN1251753C (en) | Externally-applied medicine composition for treating mastoproliferation and its prepn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee after: Beijing Ying Kerui Biological Medicine Research Co.,Ltd. Address before: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee before: Beijing Yinkeruisi Biological Medicine Research Co.,Ltd. Address after: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee after: Beijing Yinkeruisi Biological Medicine Research Co.,Ltd. Address before: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee before: Beijing Increase Biological Products Research Institute |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170504 Address after: 102209 Beijing city Changping District town Beiqijia Hongfu building room 1009 Patentee after: BEIJING INCREASE PHARMACEUTICAL INSTITUTE Co.,Ltd. Address before: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee before: Beijing Ying Kerui Biological Medicine Research Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: Double camp 102200 West Road Beijing city Changping District Science Park No. 79, No. 24 building 6 layer cloud Valley Park Patentee after: Beijing Increasepharm Co.,Ltd. Address before: 102209 Beijing city Changping District town Beiqijia Hongfu building room 1009 Patentee before: BEIJING INCREASE PHARMACEUTICAL INSTITUTE Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190621 Address after: 262513 No. 3787 New York Road, Qingzhou Economic Development Zone, Weifang City, Shandong Province Patentee after: QINGZHOU YAOWANG PHARMACEUTICAL Co.,Ltd. Address before: 102200 Beijing Changping Science and Technology Park Shuangying West Road 79 Courtyard Yunguyuan 24 Floor 6 Patentee before: Beijing Increasepharm Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190726 Address after: Unit 501C, C19 Floor, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu Province Patentee after: Suzhou Gongzheng Biomedical Technology Co.,Ltd. Address before: 262513 No. 3787 New York Road, Qingzhou Economic Development Zone, Weifang City, Shandong Province Patentee before: QINGZHOU YAOWANG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200922 Address after: 262513 No. 3787 New York Road, Qingzhou Economic Development Zone, Weifang City, Shandong Province Patentee after: QINGZHOU YAOWANG PHARMACEUTICAL Co.,Ltd. Address before: Unit 501C, C19 Floor, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu Province Patentee before: Suzhou Gongzheng Biomedical Technology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091216 Termination date: 20210111 |